DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Sign in and take the values quiz to see how this bill lines up with what you've said.
The PLASMA Act amends Medicare's manufacturer discount program to provide a phase-in for plasma-derived products (biological products derived from human blood or plasma). Under the bill, plasma-derived drugs would be subject to reduced discount requirements compared to other applicable drugs, with the discount percentage varying based on whether the beneficiary has reached their annual out-of-pocket threshold. This creates a temporary exemption or reduced obligation for manufacturers of these specialty medicines under Medicare's negotiated pricing rules.
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
Sign in to see how your representatives voted on this bill.